1. Home
  2. TKNO vs SCD Comparison

TKNO vs SCD Comparison

Compare TKNO & SCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKNO
  • SCD
  • Stock Information
  • Founded
  • TKNO 1996
  • SCD 2003
  • Country
  • TKNO United States
  • SCD United States
  • Employees
  • TKNO N/A
  • SCD N/A
  • Industry
  • TKNO Medicinal Chemicals and Botanical Products
  • SCD Trusts Except Educational Religious and Charitable
  • Sector
  • TKNO Health Care
  • SCD Finance
  • Exchange
  • TKNO Nasdaq
  • SCD Nasdaq
  • Market Cap
  • TKNO 390.7M
  • SCD N/A
  • IPO Year
  • TKNO 2021
  • SCD N/A
  • Fundamental
  • Price
  • TKNO $7.73
  • SCD $16.71
  • Analyst Decision
  • TKNO Buy
  • SCD
  • Analyst Count
  • TKNO 2
  • SCD 0
  • Target Price
  • TKNO $5.00
  • SCD N/A
  • AVG Volume (30 Days)
  • TKNO 206.5K
  • SCD 62.6K
  • Earning Date
  • TKNO 11-07-2024
  • SCD 01-01-0001
  • Dividend Yield
  • TKNO N/A
  • SCD 9.63%
  • EPS Growth
  • TKNO N/A
  • SCD N/A
  • EPS
  • TKNO N/A
  • SCD N/A
  • Revenue
  • TKNO $36,347,000.00
  • SCD N/A
  • Revenue This Year
  • TKNO $3.47
  • SCD N/A
  • Revenue Next Year
  • TKNO $12.07
  • SCD N/A
  • P/E Ratio
  • TKNO N/A
  • SCD N/A
  • Revenue Growth
  • TKNO N/A
  • SCD N/A
  • 52 Week Low
  • TKNO $1.16
  • SCD $11.33
  • 52 Week High
  • TKNO $8.91
  • SCD $15.87
  • Technical
  • Relative Strength Index (RSI)
  • TKNO 51.60
  • SCD 36.96
  • Support Level
  • TKNO $7.00
  • SCD $17.45
  • Resistance Level
  • TKNO $8.89
  • SCD $17.79
  • Average True Range (ATR)
  • TKNO 0.74
  • SCD 0.37
  • MACD
  • TKNO -0.09
  • SCD -0.14
  • Stochastic Oscillator
  • TKNO 38.24
  • SCD 20.65

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It derives maximum revenue from United States.

Share on Social Networks: